BRENDA SASSEN: Open Payments
NPI 1740614585 · LAKEWOOD, CO. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$3,956 in 175 payments from 19 companies in 2025. Trend: 2023 $2,495 · 2024 $3,510 · 2025 $3,956
Food & beverage: $3,956
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 47 | $972 |
| Phathom Pharmaceuticals, Inc. | 17 | $495 |
| Janssen Biotech, Inc. | 16 | $369 |
| Takeda Pharmaceuticals U.S.A., Inc. | 15 | $325 |
| Gilead Sciences, Inc. | 18 | $318 |
| Regeneron Healthcare Solutions, Inc. | 11 | $250 |
| GENZYME CORPORATION | 7 | $210 |
| PFIZER INC. | 9 | $179 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 6 | $125 |
| Janssen Scientific Affairs, LLC | 1 | $120 |
Products named: VOQUEZNA, TREMFYA, DUPIXENT, SKYRIZI, ENTYVIO, RINVOQ, XIFAXAN, MAVYRET.
Industry payments across CO — which companies pay providers there.
